Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04642885 · ClinicalTrials.gov registry record
Families Coping Together With Alzheimer's Disease
A clinical trial, sponsored by Yale University.
- Completed
- Registry status
- 354
- Enrollment target
NCT04642885: Completed study, sponsored by Yale University.
NCT04642885 is a clinical trial that has completed, run by Yale University. The registered enrollment target is 354 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04642885 has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- 354 participants
- Enrollment target
Study Summary
Two remote phone/zoom calls are required to assess experiences as a family coping with dementia.
Primary Outcome
(1a) Caregiver demand appraisals: 6 items from the 12-item Zarit Burden Interview (ZBI) will assess caregiver appraisals of demands (e.g., That because of the time you spend with your relative that you don't have enough time for yourself?". Caregivers self-report aspects of burden on a scale from 0 (never) to 4 (nearly always; α= .86). Higher numbers indicate higher demands. Administration is 2.5 minutes
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 354 participants |
| Start Date | 2019-06-30 |
| Est. Completion | 2024-11-30 |
What the finished NCT04642885 record still lists
NCT04642885 is an observational study that tracks outcomes without assigning an intervention. The registered 354 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT04642885 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04642885 about?
NCT04642885 is a clinical study titled "Families Coping Together With Alzheimer's Disease". Two remote phone/zoom calls are required to assess experiences as a family coping with dementia.
What is the current status of trial NCT04642885?
This trial is currently completed. The enrollment target is 354 participants. The study started on 2019-06-30. Estimated completion is 2024-11-30.
Who is sponsoring clinical trial NCT04642885?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02579967 · 354 participants · Phase 2
Pilot Trial of Allogeneic Blood or Marrow Transplantation for Primary Immunodeficiencies
- NCT02610413 · 354 participants
Whole Exome Sequencing in Finding Causative Variants in Germline DNA Samples From Patients With Hypertension Receiving Bevacizumab for Breast Cancer
- NCT05729256 · 354 participants · NA
Alcohol and "Heat of the Moment" Sexual Decision Making
- NCT06507618 · 354 participants · Phase 3
Pre-Operative Window of ET to Inform RT Decisions (POWER II)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI